Structural principles controlling HIV envelope glycosylation

Current Opinion in Structural Biology

Volumn 44, Issue , 2017, Pages 125-133

  Behrens, Anna Janina ^a   Crispin, Max ^a,b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCAN; GLYCOPEPTIDE; GLYCOPROTEIN GP 120; MANNOSE; NEUTRALIZING ANTIBODY; POLYMER; TRIMER; UNCLASSIFIED DRUG; EPITOPE; POLYSACCHARIDE; VIRUS ENVELOPE PROTEIN;

ANTIBODY RESPONSE; CELL SHAPE; HUMAN IMMUNODEFICIENCY VIRUS; MASS SPECTROMETRY; NONHUMAN; PROTEIN ANALYSIS; PROTEIN GLYCOSYLATION; PROTEIN STRUCTURE; QUANTITATIVE ANALYSIS; REVIEW; VIRUS ENVELOPE; ANIMAL; CELL MEMBRANE; CHEMISTRY; GLYCOSYLATION; HUMAN; IMMUNOLOGY; METABOLISM;

ANIMALS; CELL MEMBRANE; ENV GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; EPITOPES; GLYCOSYLATION; HUMANS; MANNOSE; POLYSACCHARIDES;

EID: 85016231197     PISSN: 0959440X     EISSN: 1879033X     Source Type: Journal    
DOI: 10.1016/j.sbi.2017.03.008     Document Type: Review

References (58)

1. 1 Lasky, L.A., Groopman, J.E., Fennie, C.W., Benz, P.M., Capon, D.J., Dowbenko, D.J., Nakamura, G.R., Nunes, W.M., Renz, M.E., Berman, P.W., Neutralization of the AIDS retrovirus by antibodies to a recombinant envelope glycoprotein. Science 233 (1986), 209–212.
2. 2 Wyatt, R., Kwong, P.D., Desjardins, E., Sweet, R.W., Robinson, J., Hendrickson, W.A., Sodroski, J.G., The antigenic structure of the HIV gp120 envelope glycoprotein. Nature 393 (1998), 705–711.
3. 3 Wei, X., Decker, J.M., Wang, S., Hui, H., Kappes, J.C., Wu, X., Salazar-Gonzalez, J.F., Salazar, M.G., Kilby, J.M., Saag, M.S., et al. Antibody neutralization and escape by HIV-1. Nature 422 (2003), 307–312.
4. 4 Moore, J.P., Sodroski, J., Antibody cross-competition analysis of the human immunodeficiency virus type 1 gp120 exterior envelope glycoprotein. J Virol 70 (1996), 1863–1872.
5. 5 Blattner, C., Lee, J.H., Sliepen, K., Derking, R., Falkowska, E., de la Pena, A.T., Cupo, A., Julien, J.P., van Gils, M., Lee, P.S., et al. Structural delineation of a quaternary, cleavage-dependent epitope at the gp41–gp120 interface on intact HIV-1 Env trimers. Immunity 40 (2014), 669–680.
6. 6 Falkowska, E., Le, K.M., Ramos, A., Doores, K.J., Lee, J.H., Blattner, C., Ramirez, A., Derking, R., van Gils, M.J., Liang, C.-H., et al. Broadly neutralizing HIV antibodies define a glycan-dependent epitope on the prefusion conformation of gp41 on cleaved envelope trimers. Immunity 40 (2014), 657–668.
7. 7 Pancera, M., Shahzad-Ul-Hussan, S., Doria-Rose, N.A., McLellan, J.S., Bailer, R.T., Dai, K., Loesgen, S., Louder, M.K., Staupe, R.P., Yang, Y., et al. Structural basis for diverse N-glycan recognition by HIV-1-neutralizing V1–V2-directed antibody PG16. Nat Struct Mol Biol 20 (2013), 804–813.
8. 8 Pejchal, R., Doores, K.J., Walker, L.M., Khayat, R., Huang, P.-S., Wang, S.-K., Stanfield, R.L., Julien, J.-P., Ramos, A., Crispin, M., et al. A potent and broad neutralizing antibody recognizes and penetrates the HIV glycan shield. Science 334 (2011), 1097–1103.
9. 9 Scharf, L., Scheid, J.F., Lee, J.H., West, A.P., Chen, C., Gao, H., Gnanapragasam, P.N.P., Mares, R., Seaman, M.S., Ward, A.B., et al. Antibody 8ANC195 reveals a site of broad vulnerability on the HIV-1 envelope spike. Cell Rep 7 (2014), 785–795.
10. 10 Walker, L.M., Huber, M., Doores, K.J., Falkowska, E., Pejchal, R., Julien, J.-P., Wang, S.-K., Ramos, A., Chan-Hui, P.-Y., Moyle, M., et al. Broad neutralization coverage of HIV by multiple highly potent antibodies. Nature 477 (2011), 466–470.
11. 11 Huang, J., Kang, B.H., Pancera, M., Lee, J.H., Tong, T., Feng, Y., Georgiev, I.S., Chuang, G.-Y., Druz, A., Doria-Rose, N.A., et al. Broad and potent HIV-1 neutralization by a human antibody that binds the gp41–gp120 interface. Nature 515 (2014), 138–142.
12. 12 Doores, K.J., The HIV glycan shield as a target for broadly neutralizing antibodies. FEBS J 282 (2015), 4679–4691.
13. 13 Doores, K.J., Burton, D.R., Variable loop glycan dependency of the broad and potent HIV-1-neutralizing antibodies PG9 and PG16. J Virol 84 (2010), 10510–10521.
14. 14 Freund, N.T., Horwitz, J.A., Nogueira, L., Sievers, S.A., Scharf, L., Scheid, J.F., Gazumyan, A., Liu, C., Velinzon, K., Goldenthal, A., et al. A new glycan-dependent CD4-binding site neutralizing antibody exerts pressure on HIV-1 in vivo. PLoS Pathog, 11, 2015, e1005238.
15. 15 Burton, D.R., Ahmed, R., Barouch, D.H., Butera, S.T., Crotty, S., Godzik, A., Kaufmann, D.E., McElrath, M.J., Nussenzweig, M.C., Pulendran, B., et al. A blueprint for HIV vaccine discovery. Cell Host Microbe 12 (2012), 396–407.
16. 16• Pritchard, L.K., Vasiljevic, S., Ozorowski, G., Seabright, G.E., Cupo, A., Ringe, R., Kim, H.J., Sanders, R.W., Doores, K.J., Burton, D.R., et al. Structural constraints determine the glycosylation of HIV-1 envelope trimers. Cell Rep 11 (2015), 1604–1613 This study shows that the native-like folding state of Env mimics is reflected in their underprocessed glycosylation profiles and shows that glycan composition can guide immunogen selection.
17. 17•• Panico, M., Bouche, L., Binet, D., O'Connor, M.J., Rahman, D., Pang, P.C., Canis, K., North, S.J., Desrosiers, R.C., Chertova, E., et al. Mapping the complete glycoproteome of virion-derived HIV-1 gp120 provides insights into broadly neutralizing antibody binding. Sci Rep, 6, 2016, 32956 A site-specific glycosylation analysis study of virion-derived gp120 that reveals the dominance of oligomannose-type glycans on almost all N-glycosylation sites.
18. 18 Stansell, E., Panico, M., Canis, K., Pang, P.C., Bouche, L., Binet, D., O'Connor, M.J., Chertova, E., Bess, J., Lifson, J.D., et al. Gp120 on HIV-1 virions lacks O-linked carbohydrate. PLoS One, 10, 2015, e0124784.
19. 19 Harvey, D.J., Crispin, M., Bonomelli, C., Scrivens, J.H., Ion mobility mass spectrometry for ion recovery and clean-up of MS and MS/MS spectra obtained from low abundance viral samples. J Am Soc Mass Spectrom 26 (2015), 1754–1767, 10.1007/s13361-015-1163-5.
20. 20 Harvey, D.J., Scarff, C.A., Edgeworth, M., Struwe, W.B., Pagel, K., Thalassinos, K., Crispin, M., Scrivens, J., Travelling-wave ion mobility and negative ion fragmentation of high-mannose N-glycans. J Mass Spectrom 51 (2016), 219–235.
21. 21 Pritchard, L.K., Harvey, D.J., Bonomelli, C., Crispin, M., Doores, K.J., Cell- and protein-directed glycosylation of native cleaved HIV-1 envelope. J Virol 89 (2015), 8932–8944.
22. 22 Leonard, C.K., Spellman, M.W., Riddle, L., Harris, R.J., Thomas, J.N., Gregory, T.J., Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells. J Biol Chem 265 (1990), 10373–10382.
23. 23 Go, E.P., Liao, H.-X., Alam, S.M., Hua, D., Haynes, B.F., Desaire, H., Characterization of host-cell line specific glycosylation profiles of early transmitted/founder HIV-1 gp120 envelope proteins. J Proteome Res 12 (2013), 1223–1234.
24. 24 Cutalo, J.M., Deterding, L.J., Tomer, K.B., Characterization of glycopeptides from HIV-I(SF2) gp120 by liquid chromatography mass spectrometry. J Am Soc Mass Spectrom 15 (2004), 1545–1555.
25. 25 Pabst, M., Chang, M., Stadlmann, J., Altmann, F., Glycan profiles of the 27 N-glycosylation sites of the HIV envelope protein CN54gp140. Biol Chem 393 (2012), 719–730.
26. 26 Zhu, X., Borchers, C., Bienstock, R.J., Tomer, K.B., Mass spectrometric characterization of the glycosylation pattern of HIV-gp120 expressed in CHO cells. Biochemistry 39 (2000), 11194–11204.
27. 27 Behrens, A.-J., Vasiljevic, S., Pritchard, L.K., Harvey, D.J., Andev, R.S., Krumm, S.A., Struwe, W.B., Cupo, A., Kumar, A., Zitzmann, N., et al. Composition and antigenic effects of individual glycan sites of a trimeric HIV-1 envelope glycoprotein. Cell Rep 14 (2016), 2695–2706.
28. 28 Guttman, M., Garcia, N.K., Cupo, A., Matsui, T., Julien, J.P., Sanders, R.W., Wilson, I.A., Moore, J.P., Lee, K.K., CD4-induced activation in a soluble HIV-1 Env trimer. Structure 22 (2014), 974–984.
29. 29•• Behrens, A.J., Harvey, D.J., Milne, E., Cupo, A., Kumar, A., Zitzmann, N., Struwe, W.B., Moore, J.P., Crispin, M., Molecular architecture of the cleavage-dependent mannose patch on a soluble HIV-1 envelope glycoprotein trimer. J Virol 91 (2017), e01816–e01894 Quantitative and detailed site-specific analysis of recombinant Env constructs by mass spectrometry that highlights the importance of the formation of correctly folded trimers for natively glycosylation HIV-1 viral spikes by presenting a detailed molecular map of trimer-associated glycan remodelling.
30. 30 Go, E.P., Herschhorn, A., Gu, C., Castillo-Menendez, L., Zhang, S., Mao, Y., Chen, H., Ding, H., Wakefield, J.K., Hua, D., et al. Comparative analysis of the glycosylation profiles of membrane-anchored HIV-1 envelope glycoprotein trimers and soluble gp140. J Virol 89 (2015), 8245–8257.
31. 31 Go, E.P., Hua, D., Desaire, H., Glycosylation and disulfide bond analysis of transiently and stably expressed clade C HIV-1 gp140 trimers in 293T cells identifies disulfide heterogeneity present in both proteins and differences in O-linked glycosylation. J Proteome Res 13 (2014), 4012–4027.
32. 32 Bonomelli, C., Doores, K.J., Dunlop, D.C., Thaney, V., Dwek Ra Burton, D.R., Crispin, M., Scanlan, C.N., The glycan shield of HIV is predominantly oligomannose independently of production system or viral clade. PLoS One, 6, 2011, e23521.
33. 33 Mizuochi, T., Matthews, T.J., Kato, M., Hamako, J., Titani, K., Solomon, J., Feizi, T., Diversity of oligosaccharide structures on the envelope glycoprotein gp 120 of human immunodeficiency virus 1 from the lymphoblastoid cell line H9. Presence of complex-type oligosaccharides with bisecting N-acetylglucosamine residues. J Biol Chem 265 (1990), 8519–8524.
34. 34 Doores, K.J., Bonomelli, C., Harvey, D.J., Vasiljevic, S., Dwek, R.A., Burton, D.R., Crispin, M., Scanlan, C.N., Envelope glycans of immunodeficiency virions are almost entirely oligomannose antigens. Proc Natl Acad Sci U S A 107 (2010), 13800–13805.
35. 35 Pritchard, L.K., Spencer, D.I., Royle, L., Bonomelli, C., Seabright, G.E., Behrens, A.J., Kulp, D.W., Menis, S., Krumm, S.A., Dunlop, D.C., et al. Glycan clustering stabilizes the mannose patch of HIV-1 and preserves vulnerability to broadly neutralizing antibodies. Nat Commun, 6, 2015, 7479.
36. 36 Coss, K.P., Vasiljevic, S., Pritchard, L.K., Krumm, S.A., Glaze, M., Madzorera, S., Moore, P.L., Crispin, M., Doores, K.J., HIV-1 glycan density drives the persistence of the mannose patch within an infected individual. J Virol 90:24 (2016), 11132–11144, 10.1128/jvi.01542-16.
37. 37• Doores, K.J., Kong, L., Krumm, S.A., Le, K.M., Sok, D., Laserson, U., Garces, F., Poignard, P., Wilson, I.A., Burton, D.R., Two classes of broadly neutralizing antibodies within a single lineage directed to the high-mannose patch of HIV envelope. J Virol 89 (2015), 1105–1118 In this study it is shown how somatic hypermutation and indels in two branches of a single antibody lineage targeting the intrinsic mannose increase neutralization breadth and potency.
38. 38 Kong, L., Lee, J.H., Doores, K.J., Murin, C.D., Julien, J.P., McBride, R., Liu, Y., Marozsan, A., Cupo, A., Klasse, P.J., et al. Supersite of immune vulnerability on the glycosylated face of HIV-1 envelope glycoprotein gp120. Nat Struct Mol Biol 20 (2013), 796–803.
39. 39 Scanlan, C.N., Pantophlet, R., Wormald, M.R., Ollmann Saphire, E., Stanfield, R., Wilson, I.A., Katinger, H., Dwek, R.A., Rudd, P.M., Burton, D.R., The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of alpha1 → 2 mannose residues on the outer face of gp120. J Virol 76 (2002), 7306–7321.
40. 40 Sok, D., Doores, K.J., Briney, B., Le, K.M., Saye-Francisco, K.L., Ramos, A., Kulp, D.W., Julien, J.P., Menis, S., Wickramasinghe, L., et al. Promiscuous glycan site recognition by antibodies to the high-mannose patch of gp120 broadens neutralization of HIV. Sci Transl Med, 6, 2014, 236ra263.
41. 41•• Sok, D., Pauthner, M., Briney, B., Lee, J.H., Saye-Francisco, K.L., Hsueh, J., Ramos, A., Le, K.M., Jones, M., Jardine, J.G., et al. A prominent site of antibody vulnerability on HIV envelope incorporates a motif associated with CCR5 binding and its camouflaging glycans. Immunity 45 (2016), 31–45 This study demonstrates how a number of intrinsic mannose patch-targeting bNAbs of the same class target a motif at the base of gp120 that is associated with CCR5 receptor binding and camouflaged by conserved glycans.
42. 42 Crispin, M., Doores, K.J., Targeting host-derived glycans on enveloped viruses for antibody-based vaccine design. Curr Opin Virol 11 (2015), 63–69.
43. 43 Ringe, R.P., Sanders, R.W., Yasmeen, A., Kim, H.J., Lee, J.H., Cupo, A., Korzun, J., Derking, R., van Montfort, T., Julien, J.-P., et al. Cleavage strongly influences whether soluble HIV-1 envelope glycoprotein trimers adopt a native-like conformation. Proc Natl Acad Sci U S A 110 (2013), 18256–18261.
44. 44 Checkley, M.A., Luttge, B.G., Freed, E.O., HIV-1 envelope glycoprotein biosynthesis, trafficking, and incorporation. J Mol Biol 410 (2011), 582–608.
45. 45 AlSalmi, W., Mahalingam, M., Ananthaswamy, N., Hamlin, C., Flores, D., Gao, G., Rao, V.B., A new approach to produce HIV-1 envelope trimers: both cleavage and proper glycosylation are essential to generate authentic trimers. J Biol Chem 290 (2015), 19780–19795.
46. 46 Binley, J.M., Sanders, R.W., Master, A., Cayanan, C.S., Wiley, C.L., Schiffner, L., Travis, B., Kuhmann, S., Burton, D.R., Hu, S.L., et al. Enhancing the proteolytic maturation of human immunodeficiency virus type 1 envelope glycoproteins. J Virol 76 (2002), 2606–2616.
47. 47 Decroly, E., Vandenbranden, M., Ruysschaert, J.M., Cogniaux, J., Jacob, G.S., Howard, S.C., Marshall, G., Kompelli, A., Basak, A., Jean, F., et al. The convertases furin and PC1 can both cleave the human immunodeficiency virus (HIV)-1 envelope glycoprotein gp160 into gp120 (HIV-1 SU) and gp41 (HIV-I TM). J Biol Chem 269 (1994), 12240–12247.
48. 48 Wheeler, S.F., Rudd, P.M., Davis, S.J., Dwek, R.A., Harvey, D.J., Comparison of the N-linked glycans from soluble and GPI-anchored CD59 expressed in CHO cells. Glycobiology 12 (2002), 261–271.
49. 49 Behrens, A.J., Seabright, G.E., Crispin, M., Targeting glycans of HIV envelope glycoproteins for vaccine design. Tan, Z., Wang, L.-X., (eds.) Chemical Biology of Glycoproteins, 1st ed., 2017, Royal Society of Chemistry.
50. 50 Mouquet, H., Scharf, L., Euler, Z., Liu, Y., Eden, C., Scheid, J.F., Halper-Stromberg, A., Gnanapragasam, P.N.P., Spencer, D.I.R., Seaman, M.S., et al. Complex-type N-glycan recognition by potent broadly neutralizing HIV antibodies. Proc Natl Acad Sci U S A 109 (2012), 3268–3277.
51. 51 Crispin, M., Harvey, D.J., Bitto, D., Halldorsson, S., Bonomelli, C., Edgeworth, M., Scrivens, J.H., Huiskonen, J.T., Bowden, T.A., Uukuniemi phlebovirus assembly and secretion leave a functional imprint on the virion glycome. J Virol 88 (2014), 10244–10251.
52. 52• Xiang, Y., Karaveg, K., Moremen, K.W., Substrate recognition and catalysis by GH47 alpha-mannosidases involved in Asn-linked glycan maturation in the mammalian secretory pathway. Proc Natl Acad Sci U S A 113 (2016), E7890–E7899, 10.1073/pnas.1611213113 Structural study of the substrate recognition of ER and Golgi α-mannosidases that reveals the importance of full steric access of the enzymes to their glycan substrates in order to achieve efficient oligomannose processing.
53. 53•• Lee, J.H., de Val, N., Lyumkis, D., Ward, A.B., Model building and refinement of a natively glycosylated HIV-1 Env protein by high-resolution cryoelectron microscopy. Structure 23 (2015), 1943–1951 Here, the authors present a high resolution cryo-EM structure of a natively glycosylated envelope mimic that provides interesting insights into the PGT128 epitope.
54. 54 Scanlan, C.N., Offer, J., Zitzmann, N., Dwek, R.A., Exploiting the defensive sugars of HIV-1 for drug and vaccine design. Nature 446 (2007), 1038–1045.
55. 55 Dunlop, D.C., Bonomelli, C., Mansab, F., Vasiljevic, S., Doores, K.J., Wormald, M.R., Palma, A.S., Feizi, T., Harvey, D.J., Dwek, R.A., et al. Polysaccharide mimicry of the epitope of the broadly neutralizing anti-HIV antibody, 2G12, induces enhanced antibody responses to self oligomannose glycans. Glycobiology 20 (2010), 812–823.
56. 56 Dunlop, D.C., Ulrich, A., Appelmelk, B.J., Burton, D.R., Dwek, R.A., Zitzmann, N., Scanlan, C.N., Antigenic mimicry of the HIV envelope by AIDS-associated pathogens. AIDS 22 (2008), 2214–2217.
57. 57 McCoy, L.E., van Gils, M.J., Ozorowski, G., Messmer, T., Briney, B., Voss, J.E., Kulp, D.W., Macauley, M.S., Sok, D., Pauthner, M., et al. Holes in the glycan shield of the native HIV envelope are a target of trimer-elicited neutralizing antibodies. Cell Rep 16 (2016), 1–12.
58. 58 Sanders, R.W., Moore, J.P., Native-like Env trimers as a platform for HIV-1 vaccine design. Immunol Rev 275 (2017), 161–182.